Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)

    NIAID offers funding for small businesses to conduct clinical trials related to its research mission, particularly encouraging high-risk studies involving non-routine interventions or administration of unlicensed products for unapproved indications.

    OverviewSimilar Grants
    OverviewSimilar Grants

    This grant is no longer accepting proposals

    National Institutes of Health has archived this opportunity.

    NIH and CDC Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Required)

    This upcoming NIH and CDC grant will invite eligible US small businesses to apply for SBIR funding for innovative research requiring clinical trials, pending program reauthorization.

    HHS-NIH11Due Apr 5, 2029

    NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)

    The NIH, CDC and FDA Small Business Innovation Research Grant helps US small businesses develop and commercialize cutting-edge health technologies, from early feasibility through advanced research.

    HHS-NIH11Due Apr 5, 2027

    NIAID Clinical Trial Implementation Cooperative Agreement

    This grant supports investigator-initiated, milestone-driven clinical trials in allergy and infectious diseases, funding trial implementation, training, data management, and related research activities.

    HHS-NIH11Due Jul 5, 2029

    SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Not Allowed)

    NIH will soon offer funding for small businesses with recent SBIR/STTR Phase II/IIB awards to support technical assistance and late-stage R&D for commercialization, excluding clinical trials.

    HHS-NIH11Due Apr 5, 2029

    Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)

    NHLBI plans to fund single-site clinical trials (R61/R33) testing therapeutic, behavioral, or prevention strategies, encouraging innovative designs.

    HHS-NIH11Due Nov 2, 2028